The importance of assessing the dose actually administered in pharmacokinetic trials.
Buclin
Thierry
T
Division of Clinical Pharmacology and Toxicology, Beaumont 633, University Hospital of Lausanne (CHUV), 1011 Lausanne, Switzerland. thierry.buclin@chuv.hospvd.ch
Perrottet
Nancy
N
Biollaz
Jerome
J
D019540:Area Under Curve; D002986:Clinical Trials as Topic / Q000592:standards*; D004305:Dose-Response Relationship, Drug; D015507:Drugs, Investigational / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006801:Humans; D017410:Practice Guidelines as Topic
D015507:Drugs, Investigational